Healthcare | December 08, 2025
New study aims to improve mobility for millions with flat foot and knee osteoarthritis
The launch of the study was on the occasion of the International Day of Persons with Disabilities
The launch of the study was on the occasion of the International Day of Persons with Disabilities
Alport Syndrome is caused by genetic mutations affecting type IV collagen in the kidneys, ears, and eyes
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
LYMPHIR addresses a clear clinical need in a disease with limited treatment options
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
The trial tested six injectable doses and three oral doses over as long as 36 weeks
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
Subscribe To Our Newsletter & Stay Updated
